Porton Pharma Solutions Ltd.

¥24.22As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300363Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 1.51%
Div yield 0.37%
ROE (2.84%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.56
PE TTM —
TSR TTM (8.73%)
Mkt cap ¥12.99B
ROIC 5.03%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥30
23.12%
(30.13%)
Buy 10|0|9|3|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.33
0.35
0.36
0.34
10.02%
5.22%
0.86%
(1.83%)
Revenue¥B
1.085
1.112
1.163
1.146
1.60%
2.16%
7.01%
5.02%
Peers (US$1.947B)
Cap (US$)
PE
1.926B
13.11x
1.907B
—
Capital
TTM
5Y
10Y
Leveragex
1.395
0.322
0.259
EBIT/Intx
0.843
0.520
0.358
Own earn%
(33.15)
59.79
95.76
Sh yield%
36.34
45.89
43.34
Owners
Insiders/Inst%
11.20
36.88
Short interest%
5.60
SBC / revenue%
2.71
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
15–23
$1 testx
0.5
Incr. ROIC%
3